GAIL (India) Limited has secured regulatory approval for its strategic equity investment in Leafiniti Bioenergy Private Limited, marking a significant milestone in the state-owned energy company's expansion into the bioenergy sector.

Regulatory Approval Details

The Department of Investment and Public Asset Management (DIPAM) has granted its concurrence for GAIL's equity participation proposal. The approval was formally communicated through the Ministry of Petroleum and Natural Gas (MOPNG) in a letter dated 04.02.2026, which referenced DIPAM's office memorandum issued on 22.01.2026.

Background and Timeline

This approval follows GAIL's earlier commitment to the investment, as evidenced by the execution of a Share Subscription cum Shareholders Agreement with Leafiniti Bioenergy Private Limited on 11.08.2025. The company had previously disclosed this agreement to the stock exchanges as part of its regulatory compliance obligations.

Strategic Significance

The investment represents GAIL's continued focus on diversifying its energy portfolio and expanding into renewable energy segments. Leafiniti Bioenergy operates in the bioenergy sector, aligning with GAIL's broader strategic objectives in clean energy initiatives.

Compliance and Disclosure

GAIL has made this disclosure in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company secretary, Mahesh Kumar Agarwal, signed the disclosure document on 05.02.2026, ensuring timely communication to both the National Stock Exchange of India Limited and BSE Limited.

The approval from DIPAM, which oversees strategic decisions for public sector enterprises, provides GAIL with the necessary regulatory clearance to proceed with its equity participation in Leafiniti Bioenergy Private Limited.

GAIL (India) Limited has announced its quarterly earnings conference call for Q3 FY26, scheduled for February 2, 2026, at 11:00 AM IST. The company has released its investor presentation covering the nine-month period of FY26, providing comprehensive insights into its operational and financial performance across various business segments.

Physical Performance Highlights

The company's operational metrics for 9M FY26 demonstrate strong performance across key business verticals. Natural gas transmission reached 123 MMSCMD, while natural gas marketing achieved 105 MMSCMD during the period.

The natural gas marketing segment shows diversified sourcing, with APM/NAPM contributing 35%, RLNG/Spot accounting for 50%, RIL & BP MDP at 3%, and overseas sales representing 12% of the total 104.97 MMSCMD volume.

Financial Performance Analysis

GAIL's standalone financial results for 9M FY26 reflect the company's operational dynamics during the period. The company reported gross turnover of Rs. 103,738 crore, with EBITDA of Rs. 10,943 crore and profit after tax of Rs. 5,706 crore.

On a consolidated basis, the company's performance shows similar trends with gross turnover of Rs. 106,217 crore, EBITDA of Rs. 11,821 crore, and PAT of Rs. 6,098 crore for 9M FY26.

Balance Sheet and Capital Structure

As of December 31, 2025, GAIL maintains a robust balance sheet with total assets of Rs. 119,551 crore. The company's capital structure includes equity of Rs. 75,147 crore and liabilities of Rs. 44,404 crore.

Capital Expenditure Strategy

GAIL's capital expenditure profile demonstrates its commitment to infrastructure development and renewable energy initiatives. For FY25, the company invested Rs. 10,512 crore across various segments, with pipeline projects receiving the largest allocation at Rs. 4,570 crore (44%), followed by net zero and renewables at Rs. 2,653 crore (25%).

The estimated capital expenditure for FY26 is approximately Rs. 10,700 crore, with increased focus on net zero and renewable initiatives at Rs. 3,000 crore (28%) and pipeline development at Rs. 2,750 crore (26%).

Regulatory Compliance

The earnings conference call announcement and presentation release comply with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both NSE (scrip code: GAIL-EQ) and BSE (scrip code: 532155) about the scheduled earnings call, ensuring transparency and regulatory adherence in its investor communication process.